Causes
Target & mechanism
Define the disease mechanism and translational objective a candidate is designed to address.
LEWOS BIOTECHNOLOGYNEUROSCIENCE · PRECLINICAL CROExplore · Discover · AdvanceAbout LEWOS
Founded in 2022, LEWOS brings together seven neuroscience PhDs focused on CNS disease models, preclinical efficacy and delivery evaluation. Our scientists participate in study design, execution and interpretation, working with R&D teams to turn targets, models, routes and endpoints into executable plans.
Start a conversationSCIENTIFIC FOUNDATION
Scientific team & experience
PhD scientists participate in study design, execution and interpretation. The core team has published 80+ papers across Cell, Nature Neuroscience, Neuron, Molecular Psychiatry and Nature Communications, and holds 30+ national patents.
4C scientific decision
Translate cause, mechanism, manifestation and treatment choice into target, model, endpoint and dosing decisions.
Core mechanisms
Best-fit model
Match disease stage, animal background and intervention window.
Clinical manifestation
Core endpoints
Combine behavioral, molecular, histology, imaging and electrophysiology readouts.
Cure choice
Dosing strategy
Design the route, dose frequency and tissue-distribution validation.
Collaboration network
Universities, hospitals and biopharma teams connect research questions to translational development.
Universities & research institutes
Hospitals
Industry & specialist organisations
Technical contact
Discuss your target, model or delivery question and learn about study plans, project scope and pricing.